Nasal drug products and methods of their use | Patent Publication Number 20170151231

US 20170151231 A1
Patent NumberUS 09707226 B2
Application Number15428705
Filled DateFeb 9, 2017
Priority DateMar 14, 2014
Publication DateJun 1, 2017
Original AssigneeEmergent Biosolutions Inc.
Opiant Pharmaceuticals
Current AssigneeIndivior Inc.
Inventor/ApplicantsRoger Crystal
Michael Brenner Weiss
Robert Gerard Bell
Fintan Keegan
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.